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HUMAN  IMMUNE  RESPONSES  TO  HAPTEN-CONJUGATED 
CELLS 
I.  Primary and Secondary Proliferative Responses in Vitro* 
BY MICHAEL F.  SELDIN AND ROBERT R.  RICH$ 
(From the Departments of Microbiology and Immunology and of  Medicine, Baylor College of 
Medicine, and the Methodist and Veterans Administration Hospitals, Houston, Texas 77030) 
The association between the human major histocompatibility  complex (MHC)  1 
and a variety of diseases has been well established in the last few years (1, 2). 
In contrast with the mouse, however, in which the availability of H-2  recombi- 
nant strains has permitted rapid progress, relatively little is known about the 
functional role of MHC genes in human immune responses. In the mouse, genes 
within specific regions of the H-2  complex determine susceptibility to certain 
diseases (3), control immune responses to numerous antigens (4), and determine 
proliferative and  cytotoxic immune  responses  of T  cells  (5-8).  Thus,  T-cell- 
mediated cytotoxicity against virus-infected (5) or hapten-modified cells (6) and 
against  minor  histocompatibility locus  antigens  (7)  requires  syngenicity be- 
tween target and original stimulator cells with respect to K  or D  regions. On 
the other hand, proliferative responses to protein antigens are facilitated by I 
region  homology between  interacting macrophages  and  lymphocytes in both 
guinea  pigs  and  mice  (8,  9).  Secondary  proliferative  responses  to  hapten- 
modified cells may also be facilitated by homology within H-2  (10). 
Recently Newman et al. (11) have reported that primed human lymphoid cells 
respond to hapten-conjugated lymphoid cells in vitro. Using a  similar system, 
the  present  report  describes  development of a  human  model  to  study both 
primary  and  secondary proliferative responses  to  trinitrophen.ylated human 
cells. Moreover, the data connote a role for the human MHC in T-cell recognitive 
processes.  Human lymphocytes primed to hapten-modified autologous periph- 
eral blood mononuclear cells gave substantially greater proliferative responses 
when  restimulated with  autologous than  with  allogeneic  hapten-conjugated 
cells.  HLA-A and HLA-B locus antigens do not appear to participate in such 
restimulation, whereas B-cell typing studies strongly suggest a  role for gene 
products of the HLA-D region in definition of functional immunogenic units. 
* Supported by National Institutes of Health grants AI 13810 and RR 00350. Computational 
assistance was provided by the CLINFO  Project, National Institutes of Health Contract NO1-RR- 
5-2118. 
$ Investigator, Howard  Hughes Medical  Institute. 
1Abbreviations  used  in  this  paper:  HBSS, Hanks' balanced salt  solution; MHC, major 
histocompatibility  complex; MLC, mixed leukocyte  reaction; PBMCs, peripheral blood mononu- 
clear cells; TNP, trinitrophenyl. 
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Materials and Methods 
Peripheral Blood Mononuclear Cells (PBMCs).  Heparinized venous blood was obtained from 
healthy  human  subjects  and  PBMCs  were  isolated  by  flotation  on  sodium  diatrizoate-Fieoll 
cushions (Isolymph; Teva, Ltd., Jerusalem, Israel) by previously described techniques (12).  Cells 
were  washed  twice  with  Hanks'  balanced  salt  solution  (HBSS;  Microbiological  Associates, 
Walkersville, Md.) before hapten conjugation or cell culture. Cells obtained in this fashion contain 
approximately  80%  lymphocytes  and  20%  monocytes.  An  average  of 70%  of these  cells  were 
classified as T cells on the basis of E-rosetting with sheep erythrocytes. 
Trinitrophenyl (TNP)-Conjugated Cells.  Hapten-modified PBMCs were prepared by modifi- 
cations of the technique described by Shearer for murine cells (13).  Briefly, 5-25  ×  10  e cells/ml 
were incubated 12 min at 37°C with 2 mM trinitrobenzene sulfonic acid (Nutritional Biochemicals 
Corp.,  Cleveland, Ohio) in HBSS buffered with 50 mM  Hepes  (Microbiological Associates) and 
titrated to pH  7.8 with 1 N  NaOH.  Cells were washed three times with Hepes-buffered  HBSS 
supplemented with 10 mg/ml glycylglycine (Grand Island Biological Co., Grand Island, N.Y.) and 
5%  heat-inactivated  fetal  calf serum  (Grand  Island  Biological  Co.)  to  remove  all  unreacted 
trinitrobenzene sulfonic acid. 
Cell Culture  Techniques.  Cells  were  cultured  in  RPMI-1640  (Grand  Island  Biological  Co.) 
supplemented with 20%  AB positive heat-inactivated pooled human plasma,  2 mM L-glutamine 
(Microbiological  Associates)  and  50  #g/ml  gentamicin  (Schering  Corp.,  Kenilworth,  N.J.). 
Cultures were buffered to pH 7.2 with 25 mM Hepes and 1 N  NaOH and were incubated in a 5% 
CO2 atmosphere at 37°C. 
For primary  stimulation cells were cultured in either round-bottom microculture  wells  (1S- 
MRC-96; Linbro Scientific Inc., Becton, Dickinson & Co., New Haven, Conn.) or in round-bottom 
17  ×  100-mm tubes  (2001;  BioQuest,  BBL,  &  Falcon Products,  Cockeysville,  Md.).  In general, 
tubes were utilized in long-term cultures for ease in media replacement. Responder and stimulator 
cells were each cultured at a final concentration of 7.5  ×  105 cells/ml in cultures of 0,2 ml (micro- 
culture wells) or 2 ml (tubes). For primary sensitization the cells were cocultured for 21-30 days. 
Primary proliferative responses were monitored from 3 to 25 days after culture initiation. Stimu- 
lator cells were treated with 500 or 4,000 rads 137Cs (dose rate 6,000 rads/min) or with mitomycin C 
(Sigma Chemical Co., St. Louis, Mo., 50/zg/ml for 30 min at 37~C). Inactivated stimulator cells are 
designated throughout with a  subscript x.  Culture media were replaced with fresh media once 
each week. 
For  secondary  restimulation,  primed  cells were  harvested,  washed once  with  medium,  and 
cocultured  in microculture  wells  at  a  final concentration of 7.5  x  105 viable cells/ml,  with an 
equal concentration of fresh stimulator cells.  Stimulator cells in secondary cultures were either 
TNP-conjugated  or unconjugated,  and  in  all experiments were  inactivated with  4,000  rads T- 
irradiation. 
Proliferative responses were assessed by addition of 1.0 /zCi of tritiated thymidine (sp act 2.0 
Ci/mM; New England Nuclear Corp., Boston, Mass.) to cultures for the final 20 h of the incubation 
period. 
HLA  Typing.  Typing  for  HLA-A  and  HLA-B  locus  antigens  was  by  standard  serologic 
techniques, employing the microcytotoxicity assay (14).  All serologic procedures were performed 
by personnel of the Methodist Hospital tissue typing laboratory. 
B-Cell Antigen Typing.  B-cell antigens were detected by using the method ofTing et al. (15). 
Briefly,  a  B-cell-enriched population  was  prepared  by  rosetting PBMCs  with  neuraminidase- 
treated sheep erythrocytes over sodium diatrizoate-Ficoll cushions. The non-erythrocyte rosetting 
(interface  fraction  a~er  centrifugation)  B-cell-enriched  population  was  then  typed  for  B-cell 
antigens by using anti-B cell antisera trays kindly provided by Dr. Paul Terasaki,  University of 
California at Los Angeles, utilizing techniques similar to A and B locus typing. 
Data Analysis.  Data from separate experiments are expressed as mean cpm of three to four 
replicate cultures with the SEM. Net counts per minute (E-C) were calculated by subtracting cpm 
of responses to unconjugated stimulators (C) from cpm of cultures with TNP-conjugated stimulator 
cells (E). E-C errors were determined by the formula for propagation of error. Stimulation indices 
(E/C) were calculated by dividing (E) by (C) values as defined above. Two-tailed rank-sum tests 
were performed to determine significant differences between experimental groups. MICHAEL  F.  SELDIN  AND  ROBERT  R.  RICH 
TABLE  I 
Primary Responses  of Fresh PBMCs to Autologous TNP-Conjugated Cells* 
1673 
High responders$  Unconjugated§  TNP-Conjugated  E-C  E-C Rangell 
I  798 ±  139  20,813  ±  1,781  20,015  ±  1,951  11,370 -  20,015 
Q  2,116  ±  984  17,920  ±  1,768  15,804  ±  2,023  6,746 -  19,079 
A  377 ±  48  7,533  z  822  7,156  ±  825  6,760 -  15,507 
E  587 ±  139  7,306  ±  726  6,718  ±  735  5,842 -  6,718 
Low 
responders 
G  1,310 -+ 198  4,520  ±  644  3,210  x  674  194 -  4,087 
N  566 -+ 151  2,213  ±  682  1,646  ±  698  1,104 -  1,646 
L  493  ±  49  871  ±  319  378  _  323  187 -  378 
K  322 -+  79  997  -+  50  675  _+ 105  -472 -  675 
*  1.5 x  105 responder cells, cocultured with 1.5 ×  105 unconjugated or TNP-conjugated inactivated 
autologous cells, were  pulsed with  [:~H]thymidine for 20 h  5-6 days after culture in microtiter 
wells. 
$ High and low responders were distinguished using 2-7 separate experiments for each individual. 
Each  low  responder  was  assayed  with  a  high  responder  in  at  least  two  experiments.  High 
responders in all experiments had E/C  values >  5,  whereas low responders in all experiments 
had E/C values <  5. 
§ Data  are  taken  from  representative  experiments with  triplicate  or quadruplicate  determina- 
tions. 
II E-C range of all experiments performed for each subject. 
Results 
Primary TNP-Conjugate Responses.  In  vitro  coculture  of  PBMCs  with 
autologous TNP-conjugated cells stimulated primary proliferative responses in 
16 of 18 individuals tested. Patterns of relative responsiveness were consistent 
and clearly differentiated high and tow responders  (Table  I).  5 of 18  subjects 
tested were classified as  low responders in that they always had stimulation 
indices of less than 5.  High responders had an average stimulation index of 11 
_+  1 (E/C  _+  SEM) compared with 2.1  _+  0.3 for low responders. This difference 
was not due to a shift in response kinetics, nor was it due to a general decrease 
in response capacity of low responder subjects in that high and low responders 
exhibited comparable  proliferative responses  to  phytohemagglutinin and  de- 
layed skin test reagents (D.  L. Peavy and M.  F.  Seldin, unpublished observa- 
tions). 
Studies of the effect of stimulator cell inactivation on primary proliferative 
responses to  TNP-conjugated cells revealed no  difference in the proliferative 
responses of lymphocytes from high responder subjects to stimulators inacti- 
vated  with  4,000 rads  compared  with  500  rads.  In  contrast,  low  responder 
lymphocytes, did not respond to high-dose irradiated stimulator cells, although 
marginal but significant responses were generated with cells from three out of 
five low responder subjects when stimulator cells were not inactivated or when 
they were inactivated with 500 rads or with mitomycin C. 
Secondary Responses.  Restimulation of primed responder cells 3 wk after 
initial sensitization generated a secondary proliferative response to TNP-conju- 
gated autologous PBMCs. The kinetics of the primary and secondary responses 
were  easily distinguishable  (Fig.  1).  Primary responses  showed  little  if any 1674  HUMAN  PROLIFERATIVE  RESPONSES  TO  HAPTEN-CONJUGATED  CELLS 
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FIG,  1.  Kinetics of primary and secondary proliferative responses to  hapten-modified 
autologous cells.  Data  were taken  from three  separate experiments and  normalized to 
percent maximal E-C response. 
proliferation  at  day 3  and  peaked at  day 8;  in  contrast,  secondary responses 
were maximal  at day 3 and had diminished  substantially by day 6.  The peak 
secondary response was usually greater than  the maximum primary response 
seen at a later time point.  The stimulation index of secondary responses varied 
from 6.5-20 and averaged 14-fold at day 3. PBMCs precultured for 3 wk without 
stimulator cells generated responses consistent with primary responses, both in 
magnitude  and  kinetics,  when  TNP-conjugated  stimulator  cells  were  added 
after the preincubation period. 
In  general,  cells from  subjects which  gave low primary  responses failed to 
give responses after secondary restimulation.  Low primary responder G (Table 
I), however, gave both primary and secondary responses when primary stimu- 
lators  were  mitomycin  C-treated  (Table  II)  or  not  inactivated  (Table  III), 
although  no  secondary  response  was  seen  when  primary  stimulators  were 
treated with 4,000 rads.  Secondary responses were not affected by inactivation 
of secondary stimulators with the high dose (4,000 rads) ofT-irradiation. 
Preferential  Restimulation  with  Autologous  TNP-Conjugated  Cells.  To 
investigate  whether  secondary  TNP-conjugate  responses  were  dependent  on 
recognition of some autologous determinants  in addition to the hapten moiety, 
primed  respenders  were restimulated  with both autologous and  heterologous 
TNP-modified PBMCs. The results of one such experiment are seen in Table II. 
In this experiment a  self-preference in the secondary response was seen. That 
is,  the  response to autologous TNP-conjugated  stimulators  was much  greater 
than that to allogeneic TNP-conjugated stimulators. In contrast to data reported 
in the mouse, in which cells primed with TNP-conjugated autologous cells were 
unresponsive  to  alloantigens  (10),  the  response  of autologous TNP-conjugate 
primed  cells  to  alloantigen  was  often  accelerated.  Furthermore  unprimed 
precultured cells developed proliferative responses following the usual kinetics 
of human MLC responses. 
Influence  of HLA-A  and HLA-B  Locus Determinants  on  Secondary  TNP- 
Conjugate Responses.  We next considered whether MHC determinants  were 
involved  in  the  recognition  of TNP-conjugated  cells.  Fig.  2  shows  a  single 
experiment in which two responders were primed to autologous TNP-conjugated 
PBMCs and then restimulated  with the same panel  of three  stimulators  who MICHAEL  F.  SELDIN  AND  ROBERT  R.  RICH 
TABLE  II 
Self-Preference of Secondary Response to Hapten-Modified  PBMCs 
1675 
Stimulators*  G  Responders$ 
(HLA Phenotype) 
A  B  Unprimed  Primed 
G  Unconjugated  227 _+  34  756 _+  69 
(1,2  27,40)  TNP-Conjugated  401 -+  71  10,998 +  719 
H  Unconjugated  1,945  -+ 146  5,841 _+ 146 
(3,W33  15,17)  TNP-Conjugated  1,041  -+ 164  5,877 _+ 403 
*  TNP-conjugated or unconjugated stimulators  were fresh  PBMCs inactivated  with 4,000  rads 
and cultured at 1.5 ×  105/microtiter  well. Cultures  were harvested 68 h after  secondary 
stimulation. 
$ Responders were cultured  at 1.5 × 105 cells/microtiter  well.  Unprimed responders  were fresh 
PBMCs. Primed responders  were cocultured  3 wk with mitomycin C-inactivated  trinitrophen- 
ylated autologous cells. 
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FIG. 2,  HLA association  of  secondary  responses.  Primed responders  were  cocultured  with 
500 rad inactivated  TNP-conjugated  autologous cells  and restimulated with 4,000  rad 
inactivated  TNP-conjugated  or unconjugated cells.  Mean cpm -+ SEM  of responses to 
conjugated cells  are represented by the total  height  of each bar, with the response to 
unconjugated cells  shown in  the  clear  area.  As  will  be subsequently  discussed  (see  text  and 
Table IV)  stimulator  O shares  a D region  antigen  (DRw2) with Responder A, in  addition  to 
the  HLA-B7 antigen. 
had been typed for HLA-A  and HLA-B  locus serologic specificities.  For both 
responders  there was  a  proliferative  response  to TNP-conjugated  allogeneic 
cells in excess of that to alloantigens alone. The level of proliferation of one 
responder to TNP-conjugated  cells  that shared both HLA-A  antigens was the 
same as the response to a completely HLA-nonidentical  stimulator. That is, the 
responses  of primed  cells from subject D  to stimulator  cells O  and A  were 
essentially equivalent and were about 30% of  that to  autologous TNP-conjugated 
cells (E-C analysis).  The response of the other responder (A) showed  a much 
higher level of  proliferation to allogeneic TNP-conjugated  cells  that shared an 
HLA-B  antigen (O) than to completely HLA-nonidentical  stimulator cells  (D). 
A  further examination  of  the functional role of HLA-A  and HLA-B  antigen 
homologies  in secondary  TNP-conjugate  responses  was  therefore  performed 
(Table III).  The presence or absence of  HLA-A  antigen homology did not affect T
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TABLE IV 
DRw Typing of Subjects 
Subjects  B-Cell antigens* 
G  No antigens detected 
H  DRwl (weak reaction) 
B  Not typed 
M  DRw2, DRwl, DRw6 
O  DRw2 
J  DRw3 
P  DRw7 
T  DRw7 
C  DRw2, DRw3 (weak reaction) 
A  DRw2 
D  DRw7, DRw3 (weak reaction) 
* 1977 WHO nomenclature for D-region related (DR) antigen (17). 
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the  magnitude  of responses,  whereas  HLA-B antigen  homology correlated  in 
some but not all, combinations with higher responses. One stimulator (C) which 
shared  an HLA-B antigen  with the primed responder  (O) gave a  proliferative 
response equivalent to autologous conjugated cells. 
Influence  of HLA-D  Region  Determinants  on  Secondary  TNP-Conjugated 
Respones.  In  each  experiment  in  which  HLA-B  antigen  homology between 
stimulator  and  responder  cells  resulted  in  augmented  responses  the  antigen 
shared was HLA-B7. Our attention was therefore directed to the HLA-D region, 
since HLA-B7 is in strong linkage disequilibrium with Dw2  (16). 
Two alternative  methods,  MLC  responses to  homozygous typing cells  (Dw 
specificities) and serologic detection of B-cell antigens can be used to determine 
D  region  alloantigens.  The  B-cell antigens  utilized  in our investigation  have 
been designated DRw antigens,  corresponding to the Dw specificities detected 
by the functional tests (WHO Conference 1977 [17]). 
In the two examples where HLA-B antigen homology was clearly associated 
with a  higher response than other allogeneic stimulators  (Fig.  2, Responder A 
with Stimulator O: Table III, Responder O with Stimulator C) the individuals 
also shared  the DRw2 antigen  (Table IV).  In addition the  DRw2 antigen  was 
also  shared  (Table III,  Responder  O)  with  a  stimulator  (M)  that  was not  as 
effective as a  DRw2 negative subject (T) in restimulating the response.  It may 
be relevant  in this regard  that  subject M  was Black,  whereas with the other 
DRw homologies the subjects were Caucasian. 
More data relevant to the  question of HLA-D region antigen  association of 
the  secondary proliferative  response  are  shown  in Table  V.  Stimulators  that 
shared HLA-D region antigens with the responder cells generally gave higher 
responses, expressed as a  percentage of the response with autologous stimula- 
tors  (76.5  _+  5.3%;  mean  _+  SEM),  than  did  those  that  did  not  share  these 
antigens  (42.0  _  7.0%).  It should be noted that  in experiment  1,  stimulator  Z 
was the  son of responder A.  Thus haploidentity  in'the  one experiment  where 
this  was  examined  was  not  more  effective  than  HLA-D  antigen  homology 
between allogeneic individuals.  The data presented in this table also illustrate 
the finding that the response generated by allogeneic TNP-conjugated cells was T
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not entirely explained on the basis of shared MHC specificities, insofar as they 
were detected. 
HLA-D region determinant homology between primed responder and stimu- 
lator correlated significantly with the magnitude of the secondary TNP-conju- 
gate proliferative response. The hypothesis that the two samples (those sharing 
and not sharing  HLA-D antigens)  were drawn from the same population was 
rejected (P  <  0.01;  two-tailed rank-sum  test).  On the other hand,  stimulators 
with  HLA-A or  HLA-B  homology with the  responder  (excluding  stimulators 
where HLA-D antigen homology with the responder was also present) were not 
significantly different from stimulators with no responder homology (P >  0.2). 
Discussion 
This investigation was undertaken to develop an in vitro model for examina- 
tion  of the  functional  significance  of MHC  determinants  in  human  immune 
responses.  We studied proliferative responses of human  lymphoid cells which 
had  been  conjugated  to  a  well-defined hapten  (TNP),  based on  the  previous 
findings  of MHC  association  in  murine  responses  (10).  Recently methods for 
obtaining  primed  proliferative  and  cytotoxic  responses  to  hapten-modified 
human lymphoid cells have been reported (11, 18). Although self-preference was 
suggested, the role of the MHC, if any, in these responses was not established. 
Our experiments  demonstrate  that  under  appropriate  conditions  human  lym- 
phocytes  develop  both  primary  and  secondary  responses  in  vitro  to  TNP- 
conjugated  lymphoid  cells.  Primary  proliferative  responses  have  not  been 
previously reported for either human or murine TNP-conjugate systems. 
Based on primary proliferative responses to TNP-conjugated autologous cells, 
individuals could be segregated into high and low responders. Five of 18 subjects 
studied  were  classified  as  low  responders.  Three  of  these  low  responders 
generated minimal primary responses but were extremely sensitive to stimula- 
tor cell inactivation.  A likely explanation for this observation is that functional 
stimulator cells are required in greater numbers or for a  longer time period to 
trigger responses in these individuals.  This in turn may be caused by decreased 
efficiency in antigen presentation, or recognition, or beth. 
Although we can only speculate on mechanisms responsible for high and low 
responsiveness,  it  is  unlikely  that  previous  exposure  (priming)  to  TNP  had 
occurred. Furthermore these same subjects did not segregate into high and low 
responders  when  stimulated  with  mitogens  or  delayed  skin  test  reagents. 
Similar  phenomena  in  proliferative  responses  to  soluble  antigens  (4)  and 
cytotoxic  responses  to  TNP-conjugated  cells  (6)  in  the  mouse  have  been 
explained on the basis of Ir genes encoded within the I  region of H-2, which is 
analogous to the HLA-D region.  The possibility that high and low responsive- 
ness to TNP-conjugates in  humans  may reflect presentation  or recognition  of 
particular D  region gene products, rather than responsiveness to TNP per se, is 
therefore particularly interesting.  Responsiveness to other haptens in the same 
system may resolve this possibility. 
A major interest has been the possible involvement of MHC gene products in 
stimulation  of secondary responses.  The  data clearly demonstrate  self-prefer- 
ence in the secondary stimulation phase, although various levels of responsive- 1680  HUMAN  PROLIFERATIVE  RESPONSES  TO  HAPTEN-CONJUGATED  CELLS 
ness to allogeneic TNP-conjugated ceils were seen. Several possible mechanisms 
were considered to explain both self-preference and apparent reactivity to TNP 
on  allogeneic  ceils  in  the  secondary  response.  (a)  Since  alloantigens  can 
stimulate suppressor T-cell function (19, 20) the apparent self-preference of the 
secondary  response  may  be  due  to  the  absence  of alloantigen  determinants 
rather than a requirement for autologous structures.  We consider this explana- 
tion  unlikely  because  of the  accelerated  kinetics  of the  secondary  response. 
Furthermore,  preliminary  experiments  demonstrate  that  the  addition  of allo- 
geneic  cells  to  secondary  cultures  does not  suppress  responses  to  autologous 
TNP-conjugated stimulators.  (b)  Part  or all  of the  response  may be to TNP- 
protein on the cell surface without special regard to HLA. Self-preference may, 
therefore, be due to autologous proteins having unique determinants.  While not 
formally excluded, this possibility conflicts with the findings in murine models 
and  would not explain  our findings  of preferential  restimulation  with partial 
HLA-D  region  homologous  stimulators.  (c)  There  may  be  a  requirement 
comparable to that in murine systems for certain MHC determinant homologies. 
Our  data  did  strongly  suggest  that  D  region  homology  between  primed  re- 
sponder  and  stimulator  account  for  increased  responsiveness.  It  should  be 
stated,  however,  that  the  limited  number  of D  region  alleles  which  can  be 
currently detected constrain  this conclusion.  It is possible, of course,  that  the 
requisite  genetic  homologies  between responder  and  stimulator  cells  are  not 
with detected alloantigenic  determinants,  but with other HLA-D region gene 
products in linkage disequilibrium with the typed alleles. In murine secondary 
proliferative responses to TNP-conjugated cells a strict MHC homology restric- 
tion  was  seen,  but  intra-H-2  mapping  was  complicated  (10).  K  +  I  region 
homology was more effective in restimulating secondary responses than I region 
homology  alone.  Since  all  subjects  in  this  study  with  DRw2  homology  also 
shared the HLA-B7 antigen  a  similar cooperative interaction  between HLA-B 
and D region determinants  must be considered. 
It  must  be emphasized  that  allogeneic TNP-conjugated  cells which did not 
share  any  detected  MHC  determinants  with  the  primed  responder  still  fre- 
quently  stimulated  a  measurable  proliferative  response,  albeit  substantially 
less  than  autologous  cells.  The  role  of the  human  MHC  in  T-cell-mediated 
responses to conventional antigens is not yet clear.  Differences between appar- 
ent  mouse  and  human  homology  requirements  may  be  explained  by  more 
extensive  crossreactivities  between  human  than  routine  MHC  determinants 
(i.e.,  differences between outbred and  inbred populations).  Recent work with 
wild mice has shown that cross-reactivities in the TNP cell-mediated lymphol- 
ysis assay do occur in 1"1-2 disparate  hosts when the tl-2  haplotypes between 
stimulator and target cells are closely related (21).  A less likely explanation  is 
the possibility that the recognitive structures  in human  lymphocytes are less 
discriminating  than  murine  receptors.  That  is,  greater cross-reactivity at the 
receptor level rather  than  the  stimulator  determinant  level could account for 
disparities. 
Alternatively,  the apparently nonrestricted  component of the response may 
represent  proliferation  induced  by  TNP-conjugated  allogeneic  proteins  pre- 
sented by syngeneic macrophages.  Since syngeneic macrophages are present in MICHAEL  F.  SELDIN  AND  ROBERT  R.  RICH  1681 
both the primary and secondary phase,  MHC  restriction requirements would 
not  preclude a  proliferative response dependent on  macrophage handling of 
TNP-conjugated proteins on  the cell surface.  The much lower percentage of 
macrophage-monocytes  in murine spleen cell populations (3-5%) than in human 
PBMC populations (20-25%) could explain the strict homology requirements in 
secondary TNP-conjugate proliferative responses reported in the mouse (10). 
Recently Dickmeiss et al. (22) reported that cell-mediated cytotoxicity against 
hapten-conjugated lymphocytes is  HLA restricted. They utilized dinitrophen- 
ylated  PBMCs  from  subjects  who  had  been  contact-sensitized in  vivo  with 
dinitrochlorobenzene  or  dinitrofluorobenzene.  Aider  an  additional  in  vitro 
sensitization phase, the cytotoxic responses were largely restricted to HLA-A or 
HLA-B locus homologous hapten-conjugated targets. Thus, their findings with 
cytotoxicity contrast  with  our results that  human proliferative responses to 
hapten-conjugated cells are associated with the HLA-D region, and both sets of 
data are in accord with previous studies in mice (6, 10). 
The role of HLA determinants in recognition and/or presentation of conven- 
tional antigens may help elucidate the pathogenesis of a  variety of diseases. 
The  association of a  number of human diseases  with  certain HLA  alleles, 
probably a reflection of linkage disequilibrium, has become apparent in recent 
years (1, 2). Moreover, juvenile diabetes mellitus (23, 24) and ragweed hayfever 
(25), which are not associated with particular HLA  alleles but segregate with 
the MHC  in family studies,  may be caused in part by expression of Ir genes 
encoded in the D  region.  We found that secondary proliferative responses of 
human lymphocytes to TNP-conjugated lymphoid cells are associated with the 
HLA-D  region.  Thus  the  model we  describe has  important  implications for 
definition  of human  T  cell  recognitive  units  and  may  permit  a  functional 
characterization of the role of HLA determinants in both normal and pathologic 
states. 
Summary 
An  in  vitro  model  was  developed to  study  both  primary  and  secondary 
proliferative responses of human lymphocytes to hapten-conjugated peripheral 
blood  mononuclear cells.  Coculture of human  lymphocytes with  autologous 
trinitrophenyl (TNP)-conjugated stimulator cells resulted in primary prolifera- 
tive responses. Subjects segregated into high and low primary responders with 
mean stimulation indices of 11  and 2.1, respectively. Restimulation of primed 
cells from high responder subjects 3 wk after initial  sensitization generated 
secondary proliferative responses. 
To investigate the antigenic requirements for secondary stimulation, autolo- 
gous TNP-conjugate primed respenders were restimulated with both autologous 
and allogeneic TNP-conjugated stimulators.  In all experiments restimulation 
with  autologous  conjugated  cells  yielded substantially  greater  proliferative 
responses than with allogeneic conjugates. Experiments were then performed to 
ascertain whether HLA determinant homology between primed responder and 
stimulator cells influenced the level of secondary responsiveness. Homology for 
HLA-A and B locus serologic determinants was not associated with enhanced 
responsiveness. In contrast, D region determinant homology, detected by B-cell 1682  HUMAN PROLIFERATIVE  RESPONSES TO  HAPTEN-CONJUGATED  CELLS 
antigen  typing,  showed  a  highly  significant  positive  correlation  with  the 
magnitude  of secondary  responses.  The  data  thus  strongly  suggest  that  for 
secondary proliferative responses to TNP,  human T  cells recognize hapten in 
association with HLA-D region determinants. 
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